CEO and Founder of CellTherEx
Lindsay is the CEO and Founder of CellTherEx, a life science consultancy company, helping academics to translate their research to the clinic. She brings more than 15 years of experience in the fields of cell therapy and regenerative medicine. In short, she held international positions at Karolinska Institute, Cardiff University and Finnish Red Cross Blood Service.
Uniting academic and industrial insights
During her career, Lindsay has gained broad expert knowledge in preclinical research, clinical trial design and product development within cell therapy and regenerative medicine. Thus, she has built a wide-ranging network in the cell and gene therapy community.
Additionally, she contributes her expert knowledge as a member of numerous Scientific Advisory Boards including European Tissue Repair Society. Next to that, she is a member of the Commercialisation Committee for the International Society of Cell and Gene Therapy (ISCT).
Renowned scientific achievements
During her career, Lindsay has been presented with several awards. Beside that, she is the named inventor on numerous granted patents. Also, she has extensively published in the field of regenerative medicine. Her publications focus on the use of advanced therapies for immune mediated disorders including Graft versus Host Disease and Type I Diabetes.
Lindsay has a great success story in receiving external grant funding, clinical trial applications, GMP manufacturing as well as mentorship for spin-outs and SMEs. All in all, with the aim of supporting the transition from lab to patients.